Denis Pezet

机构：Inserm, Université Clermont Auvergne, Centre Hospitalier Universitaire de Clermont-Ferrand · ORCID：0000-0001-9416-2876

发表论文 370 篇 · 总被引 15607 次 · h-index 63

代表论文

• Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial (2024 · The Lancet · 被引 179)
• Colibactin-producing Escherichia coli enhance resistance to chemotherapeutic drugs by promoting epithelial to mesenchymal transition and cancer stem cell emergence (2024 · Gut Microbes · 被引 40)
• Safety and feasibility of chemotherapy followed by liver transplantation for patients with definitely unresectable colorectal liver metastases: insights from the TransMet randomised clinical trial (2024 · EClinicalMedicine · 被引 37)
• Learning curve for robotic‐assisted total mesorectal excision: a multicentre, prospective study (2023 · Colorectal Disease · 被引 18)
• FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (2024 · JAMA Oncology · 被引 14)
• Liver Transplantation Combined with Chemotherapy Versus Chemotherapy Alone in Patients with Definitively Unresectable Colorectal Liver Metastases (TransMet): Results from a Prospective, Multicentre, Randomised Trial (2024 · SSRN Electronic Journal · 被引 10)